On Monday, CVS Health Corp (NYSE: CVS) opened lower -3.60% from the last session, before settling in for the closing price of $60.34. Price fluctuations for CVS have ranged from $52.77 to $83.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 13.36%. Company’s average yearly earnings per share was noted -25.82% at the time writing. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
The extent of productivity of a business whose workforce counts for 300000 workers is very important to gauge. In terms of profitability, gross margin is 14.49%, operating margin of 3.33%, and the pretax margin is 2.66%.
CVS Health Corp (CVS) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of CVS Health Corp is 0.21%, while institutional ownership is 82.72%. The most recent insider transaction that took place on May 02 ’24, was worth 53,879. In this transaction Director of this company bought 1,000 shares at a rate of $53.88, taking the stock ownership to the 21,630 shares. Before that another transaction happened on May 02 ’24, when Company’s Director bought 9,181 for $54.49, making the entire transaction worth $500,294. This insider now owns 9,356 shares in total.
CVS Health Corp (CVS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 2.21 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 2.13) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.82% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Check out the current performance indicators for CVS Health Corp (CVS). In the past quarter, the stock posted a quick ratio of 0.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.20. Likewise, its price to free cash flow for the trailing twelve months is 13.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.62, a number that is poised to hit 1.64 in the next quarter and is forecasted to reach 7.31 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
The latest stats from [CVS Health Corp, CVS] show that its last 5-days average volume of 18.7 million was superior to 11.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 18.89%. Additionally, its Average True Range was 2.09.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 32.19%, which indicates a significant increase from 6.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.15% in the past 14 days, which was higher than the 30.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.82, while its 200-day Moving Average is $65.27. Now, the first resistance to watch is $59.68. This is followed by the second major resistance level at $61.18. The third major resistance level sits at $62.09. If the price goes on to break the first support level at $57.27, it is likely to go to the next support level at $56.36. Assuming the price breaks the second support level, the third support level stands at $54.86.
CVS Health Corp (NYSE: CVS) Key Stats
There are currently 1,255,373K shares outstanding in the company with a market cap of 73.18 billion. Presently, the company’s annual sales total 357,776 M according to its annual income of 8,344 M. Last quarter, the company’s sales amounted to 91,234 M and its income totaled 1,770 M.
